LLYON
li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Name LLYON
Rank No.942
Market Cap $9.11M
Fully Diluted Market Cap $9.11M
Market Share %
Trading Vol/Market Cap (24H) 37,395.17%
Circulation Supply 6.31K
Max Supply 0
Total Supply 6,310.90710224
Circulation Rate %
Issue Date --
The price at which the asset was first issued --
All-Time High 1455.0706338377172, 2026-11-05
Lowest Price 712.8133541417105, 2025-09-25
Public Blockchain LLYON
Introduction li Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes.
Sector
- common.mc-trade-zone-xStocks
Social Media
Fund Flow Analysis
|
Buy(LLYON) |
Sell(LLYON) |
Net Inflow |
| Big |
0.000 |
0.000 |
0.000 |
| Medium |
0.000 |
23.838 |
-23.838 |
| Small |
1.589 |
79.196 |
-77.607 |
| Total |
1.589 |
103.034 |
-101.445 |
Disclaimer: Data provided by cmc and should not be considered as investment advice.